, Tracking Stock Market Picks
Enter Symbol:
Vivus, Inc. (VVUS) [hlAlert]

up 1,007.20 %

Vivus, Inc. (VVUS) downgraded to Sell by Lazard

Posted on: Wednesday,  Sep 4, 2013  8:25 AM ET by Lazard

Lazard rated Sell Vivus, Inc. (NASDAQ: VVUS) on 09/04/2013, when the stock price was $12.29. Since
then, Vivus, Inc. has lost 90.97% as of 01/25/2016's recent price of $1.11.
If you would have followed this Lazard's recommendation on VVUS, you would have gained 1007.2% of your investment in 873 days.

Vivus, Inc. is a leader in the development and commercialization of innovative therapies for the treatment of sexual dysfunction and urologic disorders in men and women. They develop and market the product MUSE and the medical device ACTIS, two innovations in the treatment of erectile dysfunction. The company has partnered with Abbott Laboratories for the international marketing and distribution of its male erectile dysfunction products. VIVUS also has research and development programs in premature ejaculation and erectile dysfunction. (Company Press Release)

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/4/2013 8:25 AM Sell
as of 12/13/2013
1 Week down  -0.10 %
1 Month down  -4.28 %
3 Months up  3.75 %
1 YTD up  20.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/14/2013 8:25 AM Hold
8/7/2012 8:36 PM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy